ArticleThe Journal of pharmacology and experimental therapeutics2013

The novel anticancer agent JNJ-26854165 induces cell death through inhibition of cholesterol transport and degradation of ABCA1.

Richard J Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.